BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/3/2026 2:08:41 AM | Browse: 0 | Download: 0
 |
Received |
|
2026-06-04 00:47 |
|
Peer-Review Started |
|
2026-06-04 00:47 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2026-07-10 07:41 |
|
Revised |
|
2026-07-24 06:59 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-07-30 02:32 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-07-30 10:43 |
|
Articles in Press |
|
2026-07-30 10:43 |
|
Edit the Manuscript by Language Editor |
|
2026-08-07 08:05 |
|
Typeset the Manuscript |
|
2026-09-01 02:49 |
|
Publish the Manuscript Online |
|
2026-09-03 02:08 |
| ISSN |
2220-6132 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Observational Study |
| Article Title |
RAD51 135G>C genetic polymorphism and the risk of prostate cancer
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Sanghapriya Pal, Kiran Dahiya, Kumud Dhankhar, Rajeev Atri, Rakesh Dhankhar, Saurabh Maheswari, Hemang Kumar, Aman Chauhan and Shweta Gaur |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Kiran Dahiya, MD, Professor, Biochemistry, Pt BD Sharma Post Graduate Institute of Medical Sciences, University of Health Sciences, Rohtak 124001, Haryana, India. kirandahiya_2002@yahoo.com |
| Key Words |
Single nucleotide polymorphism; RAD51 135G>C polymorphism; Prostate cancer; Risk of disease; GC genotype; Prostate specific antigen |
| Core Tip |
Worldwide, prostate cancer is the second most common cancer of men and it is an important public health concern in India too. For this, 50 patients of prostate cancer were compared with fifty healthy controls. The genotyping for RAD51 135 G>C polymorphism was done by polymerase chain reaction-restriction fragment length polymorphism while estimation of serum total prostate specific antigen was done by enzyme linked immunosorbent assay. |
| Publish Date |
2026-09-03 02:08 |
| Citation |
Pal S, Dahiya K, Dhankhar K, Atri R, Dhankhar R, Maheswari S, Kumar H, Chauhan A, Gaur S. RAD51 135G>C genetic polymorphism and the risk of prostate cancer. World J Transl Med 2026; 12(3): 124005
|
| URL |
https://www.wjgnet.com/2220-6132/full/v12/i3/124005.htm |
| DOI |
https://doi.org/10.5528/wjtm.124005 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
